Drugs & TargetsFree CMS publishes two draft coverage determinations for molecular prostate cancer tests October 24, 2014Vol.40 No.40
Free Discounts are Owed on Some Orphan Drug Uses, HRSA Says October 24, 2014Vol.40 No.40By Paul Goldberg
Free Caris Life Sciences Lays Off Estimated 20 Percent of Staff October 24, 2014Vol.40 No.40By Paul Goldberg
Conversation with The Cancer LetterFree Einhorn: “I Still Harbor Hope For Similar Success Stories” October 24, 2014Vol.40 No.40By Matthew Bin Han Ong
FreeFunding Opportunities Stand Up To Cancer Canada to Fund Two Dream Teams October 17, 2014Vol.40 No.39
Drugs & TargetsFree Blinatumomab granted Priority Review in acute lymphoblastic leukemia October 17, 2014Vol.40 No.39
Drugs & TargetsFree Priority Review granted to lenvatinib in thyroid cancer October 17, 2014Vol.40 No.39
